Cart
sales@molnova.com
EZM0414
CAS No. 2411748-50-8
EZM0414( —— )
Catalog No. M28993 CAS No. 2411748-50-8
EZM0414 is a selective SEDT2 inhibitor that is mostly used to study diffuse large B lymphocytoma and recurrent or refractory multiple myeloma.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 619 | Get Quote |
|
| 10MG | 880 | Get Quote |
|
| 25MG | 1314 | Get Quote |
|
| 50MG | 1764 | Get Quote |
|
| 100MG | 2385 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameEZM0414
-
NoteResearch use only, not for human use.
-
Brief DescriptionEZM0414 is a selective SEDT2 inhibitor that is mostly used to study diffuse large B lymphocytoma and recurrent or refractory multiple myeloma.
-
DescriptionEZM0414 is a selective SEDT2 inhibitor that is mostly used to study diffuse large B lymphocytoma and recurrent or refractory multiple myeloma.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayChromatin/Epigenetic
-
TargetHistone Demethylase
-
RecptorHGPR91
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2411748-50-8
-
Formula Weight400.5
-
Molecular FormulaC22H29FN4O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 120 mg/mL (299.63 mM)
-
SMILESCC(=O)N1CCN(CC1)[C@H]1CCC[C@H](C1)NC(=O)C1=CC2=C(F)C=CC(C)=C2N1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Haffke M, et al. Structural basis of species-selective antagonist binding to the succinate receptor. Nature. 2019 Oct;574(7779):581-585.
molnova catalog
related products
-
DDP-38003 dihydrochl...
DDP-38003 is an novel, orally available inhibitor of histone lysine-specific demethylase 1A (KDM1A/LSD1) with IC50 of 84 nM.
-
KDM5-IN-48
A potent, selective and orally bioavailable KDM5 inhibitor with biochemical IC50 of 15.1, 4.7 and 65.5 nM for KDM5A, KDM5B and KDM5C, respectively.
-
GSK-2879552
A potent, selective irreversible inhibitor of LSD1 with Ki app of 1.7 uM.
